Skip to main content
. 2020 Aug 25;4:190. Originally published 2019 Dec 2. [Version 2] doi: 10.12688/wellcomeopenres.15565.2

Figure 3. Schematic of study design.

Figure 3.

Abbreviations: TBM, tuberculous meningitis; BMRC, British Medical Research Council; R, rifampicin; H, isoniazid; Z, pyrazinamide; E, ethambutol; FDC, fixed dose combination; caps, capsules; ART, antiretroviral therapy; AE, adverse event; SAE, serious adverse event; DILI, drug-induced liver injury.